vs
Side-by-side financial comparison of FirstCash Holdings, Inc. (FCFS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $501.3M, roughly 1.2× FirstCash Holdings, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 20.8%, a 13.7% gap on every dollar of revenue. On growth, FirstCash Holdings, Inc. posted the faster year-over-year revenue change (21.2% vs 4.8%). Over the past eight quarters, FirstCash Holdings, Inc.'s revenue compounded faster (16.9% CAGR vs 4.6%).
FirstCash Holdings, Inc. is an American pawnshop company headquartered in Fort Worth, Texas which operates retail pawn stores in the U.S. and Latin America. It is a publicly traded company listed on the Nasdaq stock exchange.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
FCFS vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $501.3M | $622.0M |
| Net Profit | $104.2M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 28.5% | 62.4% |
| Net Margin | 20.8% | 34.4% |
| Revenue YoY | 21.2% | 4.8% |
| Net Profit YoY | 24.7% | 2.9% |
| EPS (diluted) | $2.35 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $501.3M | $622.0M | ||
| Q3 25 | $411.0M | $609.3M | ||
| Q2 25 | $385.1M | $578.7M | ||
| Q1 25 | $371.1M | $568.2M | ||
| Q4 24 | $413.7M | $593.6M | ||
| Q3 24 | $363.1M | $564.7M | ||
| Q2 24 | $363.5M | $537.3M | ||
| Q1 24 | $366.8M | $568.0M |
| Q4 25 | $104.2M | $214.2M | ||
| Q3 25 | $82.8M | $288.2M | ||
| Q2 25 | $59.8M | $30.2M | ||
| Q1 25 | $83.6M | $238.3M | ||
| Q4 24 | $83.5M | $208.2M | ||
| Q3 24 | $64.8M | $544.0M | ||
| Q2 24 | $49.1M | $102.0M | ||
| Q1 24 | $61.4M | $4.8M |
| Q4 25 | 28.5% | 62.4% | ||
| Q3 25 | 27.4% | 70.1% | ||
| Q2 25 | 21.1% | 36.3% | ||
| Q1 25 | 30.0% | 94.0% | ||
| Q4 24 | 26.5% | 60.9% | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 18.2% | 50.2% | ||
| Q1 24 | 22.3% | -13.0% |
| Q4 25 | 20.8% | 34.4% | ||
| Q3 25 | 20.1% | 47.3% | ||
| Q2 25 | 15.5% | 5.2% | ||
| Q1 25 | 22.5% | 41.9% | ||
| Q4 24 | 20.2% | 35.1% | ||
| Q3 24 | 17.9% | 96.3% | ||
| Q2 24 | 13.5% | 19.0% | ||
| Q1 24 | 16.7% | 0.8% |
| Q4 25 | $2.35 | $0.49 | ||
| Q3 25 | $1.86 | $0.67 | ||
| Q2 25 | $1.34 | $0.07 | ||
| Q1 25 | $1.87 | $0.55 | ||
| Q4 24 | $1.86 | $0.46 | ||
| Q3 24 | $1.44 | $1.21 | ||
| Q2 24 | $1.08 | $0.23 | ||
| Q1 24 | $1.35 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.2M | $618.7M |
| Total DebtLower is stronger | $2.2B | $9.0B |
| Stockholders' EquityBook value | $2.3B | $9.7B |
| Total Assets | $5.3B | $19.6B |
| Debt / EquityLower = less leverage | 0.98× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.2M | $618.7M | ||
| Q3 25 | $130.2M | $938.9M | ||
| Q2 25 | $101.5M | $631.9M | ||
| Q1 25 | $146.0M | $1.1B | ||
| Q4 24 | $175.1M | $929.0M | ||
| Q3 24 | $106.3M | $950.1M | ||
| Q2 24 | $113.7M | $1.8B | ||
| Q1 24 | $135.1M | $843.0M |
| Q4 25 | $2.2B | $9.0B | ||
| Q3 25 | $2.2B | $8.9B | ||
| Q2 25 | $1.7B | $8.0B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.7B | $7.6B | ||
| Q3 24 | $1.7B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B | ||
| Q1 24 | $1.5B | $6.1B |
| Q4 25 | $2.3B | $9.7B | ||
| Q3 25 | $2.2B | $9.6B | ||
| Q2 25 | $2.1B | $9.5B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.1B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $2.0B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
| Q4 25 | $5.3B | $19.6B | ||
| Q3 25 | $5.2B | $19.3B | ||
| Q2 25 | $4.5B | $18.3B | ||
| Q1 25 | $4.4B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.4B | $18.0B | ||
| Q2 24 | $4.3B | $17.7B | ||
| Q1 24 | $4.2B | $16.1B |
| Q4 25 | 0.98× | 0.92× | ||
| Q3 25 | 1.01× | 0.93× | ||
| Q2 25 | 0.79× | 0.84× | ||
| Q1 25 | 0.83× | 0.78× | ||
| Q4 24 | 0.85× | 0.74× | ||
| Q3 24 | 0.87× | 0.74× | ||
| Q2 24 | 0.85× | 0.78× | ||
| Q1 24 | 0.75× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.6M | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.98× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.6M | $827.1M | ||
| Q3 25 | $135.8M | $702.6M | ||
| Q2 25 | $116.9M | $364.0M | ||
| Q1 25 | $126.6M | $596.1M | ||
| Q4 24 | $198.1M | $742.5M | ||
| Q3 24 | $113.1M | $703.6M | ||
| Q2 24 | $106.2M | $658.2M | ||
| Q1 24 | $122.5M | $664.6M |
| Q4 25 | 1.98× | 3.86× | ||
| Q3 25 | 1.64× | 2.44× | ||
| Q2 25 | 1.95× | 12.06× | ||
| Q1 25 | 1.51× | 2.50× | ||
| Q4 24 | 2.37× | 3.57× | ||
| Q3 24 | 1.74× | 1.29× | ||
| Q2 24 | 2.16× | 6.45× | ||
| Q1 24 | 2.00× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
